| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| MCB-613；MCB 613;MCB613 |
|
1162656-22-5 |
詳細(xì)
|
| Oxyresveratrol 3'-O-β-D-glucopyranoside；Oxyresveratrol 3'-O-beta-D-glucopyranoside |
|
144525-40-6 |
詳細(xì)
|
| CC-115；CC115;CC 115 |
|
1228013-15-7 |
詳細(xì)
|
| Givinostat hydrochloride；ITF2357;ITF-2357;ITF2357 hydrochloride;ITF2357 HCl;Givinostat HCl;Givinostat HCl. gavinostat,;ITF 2357 |
|
199657-29-9 |
詳細(xì)
|
| Monomelittoside；Danmelittoside |
|
20633-72-1 |
詳細(xì)
|
| PT-2385 |
|
1672665-49-4 |
詳細(xì)
|
| Tos-Gly-Pro-Arg-ANBA-IPA acetate；tos-GPR-ANBA-IPA acetate |
|
2070009-46-8 |
詳細(xì)
|
| Sanggenone K |
|
86450-77-3 |
詳細(xì)
|
| Sargentol |
|
623928-18-7 |
詳細(xì)
|
| Monnieriside G |
|
1401799-34-5 |
詳細(xì)
|
| Macozinone；PBTZ169 |
|
1377239-83-2 |
詳細(xì)
|
| Sitravatinib；MG516;MGCD516 |
|
1123837-84-2 |
詳細(xì)
|
| FITM |
|
932737-65-0 |
詳細(xì)
|
| A-794278 |
|
869802-57-3 |
詳細(xì)
|
| Bufotalin；Bufotaline |
|
471-95-4 |
詳細(xì)
|
| Trierucin |
|
2752-99-0 |
詳細(xì)
|
| Leptoside |
|
465-68-9 |
詳細(xì)
|
| BMS-986176 |
|
1815613-42-3 |
詳細(xì)
|
| Sacubitril sodium；AHU-377;LCZ696;AHU 377;AHU377 |
|
149690-05-1 |
詳細(xì)
|
| Pridopidine hydrochloride；Pridopidine HCl;FR310826;ASP-2314 hydrochloride;ASP2314 HCl |
|
882737-42-0 |
詳細(xì)
|
| Hecogenin；Hocogenin |
|
467-55-0 |
詳細(xì)
|
| 3-O-Acetyl-16α-hydroxytrametenolic acid；3-O-Acetyl-16 alpha-hydroxytrametenolic acid |
|
168293-13-8 |
詳細(xì)
|
| Apratoxin B |
|
444885-29-4 |
詳細(xì)
|
| GSK3326595；EPZ015938 |
|
1616392-22-3 |
詳細(xì)
|
| Cadazolid；ACT-179811 |
|
1025097-10-2 |
詳細(xì)
|
| Yoda 1 |
|
448947-81-7 |
詳細(xì)
|
| C-DIM12 |
|
178946-89-9 |
詳細(xì)
|
| LLY-507；LLY 507;LLY507 |
|
1793053-37-8 |
詳細(xì)
|
| Acridan-9-carboxylic acid, 10-methyl-, 2-(diethylamino)ethyl ester, hydrochloride |
|
69781-84-6 |
詳細(xì)
|
| Glycylhydroxyprolylproline；Tripeptide-6 |
|
22028-82-6 |
詳細(xì)
|
| Olodaterol hydrochloride；BI 1744 hydrochloride;BI-1744 HCl |
|
869477-96-3 |
詳細(xì)
|
| ETC-159；ETC159;ETC-1922159;ETC 159 |
|
1638250-96-0 |
詳細(xì)
|
| 3,4,5'-Trimethoxy-3',4'-methylenedioxy-7,9':7',9-diepoxylignan |
|
873867-94-8 |
詳細(xì)
|
| 4E-Deacetylchromolaenide 4'-O-acetate |
|
104736-09-6 |
詳細(xì)
|
| Eupalinolide I |
|
1402067-84-8 |
詳細(xì)
|
| Isolupalbigenin |
|
162616-70-8 |
詳細(xì)
|
| Apcin |
|
300815-04-7 |
詳細(xì)
|
| G244-LM |
|
1563007-08-8 |
詳細(xì)
|
| MSC 2032964A；MSC-2032964A;MSC2032964A |
|
1124381-43-6 |
詳細(xì)
|
| SR-3029；SR3029;SR 3029 |
|
1454585-06-8 |
詳細(xì)
|
| SU5201；NSC 247030 |
|
114727-43-4 |
詳細(xì)
|
| Sulfidefluor-7 AM |
|
1416872-50-8 |
詳細(xì)
|
| LJH685 |
|
1627710-50-2 |
詳細(xì)
|
| AMG9810 |
|
545395-94-6 |
詳細(xì)
|
| 1-Phenylpropane-1,2-dione；Acetyl benzoyl;1-Phenyl-1,2-propanedione |
|
579-07-7 |
詳細(xì)
|
| STING agonist-1；G10 |
|
702662-50-8 |
詳細(xì)
|
| ML264；CID-51003603 |
|
1550008-55-3 |
詳細(xì)
|
| GSK481；GSK'481 |
|
1622849-58-4 |
詳細(xì)
|
| Selonsertib；GS-4997 |
|
1448428-04-3 |
詳細(xì)
|
| Orexin 2 Receptor Agonist；OX2R |
|
1796565-52-0 |
詳細(xì)
|
| Multi-kinase inhibitor 1；Multi-kinase inhibitor I |
|
778274-97-8 |
詳細(xì)
|
| JNJ-42041935；HIF-PHD Inhibitor II |
|
1193383-09-3 |
詳細(xì)
|
| Poricoic acid AM |
|
151200-92-9 |
詳細(xì)
|
| Exeporfinium chloride；XF 73;XF73;XF-73 |
|
718638-68-7 |
詳細(xì)
|
| Avacopan；CCX168 |
|
1346623-17-3 |
詳細(xì)
|
| Rotundatin |
|
144506-16-1 |
詳細(xì)
|
| 25(S)-Ruscogenin-1-O-α-L-rhamnopyranosyl (1→2)-β-D-xylopyranoside；(1beta,3beta,25S)-3-Hydroxyspirost-5-en-1-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-xylopyranoside |
|
125225-63-0 |
詳細(xì)
|
| Axelopran；TD-1211;TD1211;TD 1211 |
|
949904-48-7 |
詳細(xì)
|
| PNU-200579；PNU 200579;PNU200579 |
|
194482-44-5 |
詳細(xì)
|
| GJ103 |
|
1459687-89-8 |
詳細(xì)
|
| Roblitinib；FGF-401 |
|
1708971-55-4 |
詳細(xì)
|
| VA5 TG2 inhibitor；VA-5;VA 5;VA5 |
|
2088001-24-3 |
詳細(xì)
|
| Yadanzioside K |
|
101559-98-2 |
詳細(xì)
|
| Leptine I, from Solanum chacoense；Leptine I |
|
101030-83-5 |
詳細(xì)
|
| m-Anisidine, 4-(heptyloxy)- |
|
15382-63-5 |
詳細(xì)
|
| AT 4930；AT4930;AT-4930 |
|
123016-40-0 |
詳細(xì)
|
| Clodronic acid disodium salt；Loron;Lodronate;Clodronate Disodium |
|
22560-50-5 |
詳細(xì)
|
| Lanost-7,9(11)-diene-3,24,25-triol-, (3beta,24S)- |
|
107900-79-8 |
詳細(xì)
|
| Polyporusterone B；(1R,2R,4S,5R,7R,11R,14S,15R)-14-[(2R,3R)-2,3-dihydroxy-6-methyl-5-methylideneheptan-2-yl]-4,5,11-trihydroxy-2,15-dimethyltetracyclo[8.7.0.02,?.011,1?]heptadec-9-en-8-one |
|
141360-89-6 |
詳細(xì)
|
| Schisantherin B；Schizantherin-B;Wuweizi ester-B;Gomisin-B |
|
58546-55-7 |
詳細(xì)
|
| Lys05；Lys01 trihydrochloride |
|
1391426-24-6 |
詳細(xì)
|
| Pimodivir；VX-787 |
|
1629869-44-8 |
詳細(xì)
|
| Dobutamine lactobionate |
|
104564-71-8 |
詳細(xì)
|
| Monoethyl itaconate |
|
57718-07-7 |
詳細(xì)
|
| Nanterinone mesylate；UK61260;UK 61260;UK-61260 |
|
102791-74-2 |
詳細(xì)
|
| GSK-872；GSK2399872A;GSK'872;GSK872 |
|
1346546-69-7 |
詳細(xì)
|
| S1p receptor agonist 1；S1p-receptor-agonist-1 |
|
1514888-56-2 |
詳細(xì)
|
| β-Gentiobiose |
|
554-91-6 |
詳細(xì)
|
| Futibatinib；FGFR-IN-1;TAS120 |
|
1448169-71-8 |
詳細(xì)
|
| BFH772；BFH-722 |
|
890128-81-1 |
詳細(xì)
|
| Acumapimod；BCT-197 |
|
836683-15-9 |
詳細(xì)
|
| SZL P1-41 |
|
222716-34-9 |
詳細(xì)
|
| GSK2983559 active metabolite；RIPK2 inhibitor 1;RIPK2-IN-1;GSK2983559 |
|
1423186-80-4 |
詳細(xì)
|
| LDN-193189 2HCl；DM-3189 2HCl |
|
1435934-00-1 |
詳細(xì)
|
| HAMNO；NSC111847 |
|
138736-73-9 |
詳細(xì)
|
| COH29；RNR Inhibitor COH29 |
|
1190932-38-7 |
詳細(xì)
|
| Azido-PEG12-t-butyl ester |
|
1818294-45-9 |
詳細(xì)
|
| NSC23005 Sodium |
|
1796596-46-7 |
詳細(xì)
|
| CBL0137 hydrochloride；CBLC137;CBL0137;Curaxin-137 hydrochloride;CBL-C137 hydrochloride;Curaxin 137 |
|
1197397-89-9 |
詳細(xì)
|
| Ralinepag；APD811 |
|
1187856-49-0 |
詳細(xì)
|
| MFCD28987368 |
|
1610413-97-2 |
詳細(xì)
|
| Tegatrabetan；BC2059 |
|
1227637-23-1 |
詳細(xì)
|
| Kansuiphorin C；KPC |
|
133898-77-8 |
詳細(xì)
|
| Heteroclitin C |
|
140460-42-0 |
詳細(xì)
|
| Platycoside M1 |
|
917482-67-8 |
詳細(xì)
|
| Phyltetralin |
|
123048-17-9 |
詳細(xì)
|
| Notoginsenoside T5 |
|
769932-34-5 |
詳細(xì)
|
| Methyl salvionolate A |
|
1015171-69-3 |
詳細(xì)
|
| Methyl 4-caffeoylquinate |
|
123372-74-7 |
詳細(xì)
|
| Kushenol M |
|
101236-51-5 |
詳細(xì)
|